Data
Sexually Transmitted Infections Pipeline
Developed as part of the G-FINDER project, this pipeline captures critical products for three sexually transmitted infections (STIs) with a risk of antimicrobial resistance. This unique database covers drugs, vaccines, biologics, microbicides and diagnostics marketed and/or in active development between 2021 and 2024.
Related insights & reports

45 min read
A New Era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual & reproductive health and women’s health issues


20 min read
European Investment in Sexual & Reproductive Health R&D: Steady Overall but Room to Grow
This snapshot offers insights into European R&D funding from 2018 to 2022 for sexual & reproductive health issues.


45 min read
G-FINDER 2023 Sexual & Reproductive Health Research & Development report: Beyond Spillovers
The 2023 report on investment in R&D for reproductive, sexual, maternal or women's health issues produced through the G-FINDER project
